ArticleBritish journal of cancer1999
Absence of mutations in the ATM gene in forty-seven cases of sporadic breast cancer.
Article in British journal of cancer, 1999. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed.
- The Breast Cancer Tumor Suppressor TRIM29 Is Expressed via ATM-dependent Signaling in Response to Hypoxia.The Journal of biological chemistry · 2016Article
- Rare, evolutionarily unlikely missense substitutions in ATM confer increased risk of breast cancer.American journal of human genetics · 2009Article
- Rapid flow cytometry-based structural maintenance of chromosomes 1 (SMC1) phosphorylation assay for identification of ataxia-telangiectasia homozygotes and heterozygotes.Clinical chemistry · 2009Article
- Single nucleotide polymorphism D1853N of the ATM gene may alter the risk for breast cancer.Journal of cancer research and clinical oncology · 2008Article
- Article
- ATM variants 7271T>G and IVS10-6T>G among women with unilateral and bilateral breast cancer.British journal of cancer · 2003Article
- Genes other than BRCA1 and BRCA2 involved in breast cancer susceptibility.Journal of medical genetics · 2002Review
- Missense mutations but not allelic variants alter the function of ATM by dominant interference in patients with breast cancer.Proceedings of the National Academy of Sciences of the United States of America · 2002Article
- Article
- Global analysis of ATM polymorphism reveals significant functional constraint.American journal of human genetics · 2001Article
- Screening breast cancer patients for Norwegian ATM mutations.British journal of cancer · 2000Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Epidemiological evidence points to an increased risk of breast cancer in ataxia telangiectasia (AT) heterozygote women. Previous attempts to screen early onset or familial breast cancer patients failed to confirm an association. The issue of AT and late onset sporadic breast cancer remained unresolved. We screened 47 women who developed later onset, sporadic breast cancer for ataxia telangiectasia mutated (ATM) mutations. No mutations were found.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.